(Q33391521)

26 July 2017

1 reference

title

von Willebrand factor: clinical features of inherited and acquired disorders (English)

1 reference

26 July 2017

A L Bloom

1

1 reference

PubMed ID

2072762

26 July 2017

language of work or name

English

0 references

publication date

1 July 1991

1 reference

26 July 2017

1 reference

26 July 2017

66

1 reference

26 July 2017

7

1 reference

26 July 2017

743-751

1 reference

Bleeding time, blood groups and von Willebrand factor

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Relation between growth hormone levels and Von Willebrand factor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Treatment of von Willebrand's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

The Factor VIII Abnormality in Severe von Willebrand's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand's disease in western Europe and Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Acquired immunodeficiency syndrome and other possible immunological disorders in European haemophiliacs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

High potency factor VIII concentrate: More effective than cryoprecipitate in a patient with Von Willebrand's disease and inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962088-6

10.1016/S0025-6196(12)62088-6

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

2072762